New cancer clinical trial: A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors

Published on: December 03, 2018 at 12:00PM
Condition:   Solid Tumors
Intervention:   Drug: INCB086550
Sponsor:   Incyte Corporation
Not yet recruiting
https://ift.tt/2QwiI4G